Alexander O. Schuth - Oct 4, 2021 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)

Role
COO and Secretary
Signature
/s/ Tyler Nielsen, by power of attorney
Stock symbol
DNLI
Transactions as of
Oct 4, 2021
Transactions value $
-$505,605
Form type
4
Date filed
10/6/2021, 06:14 PM
Previous filing
Sep 22, 2021
Next filing
Nov 8, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNLI Common Stock Sale -$301K -5.99K -1.24% $50.24 477K Oct 4, 2021 See footnote F1, F2, F3, F4
transaction DNLI Common Stock Sale -$204K -4.01K -0.84% $51.04 473K Oct 4, 2021 See footnote F1, F3, F4, F5
holding DNLI Common Stock 86.5K Oct 4, 2021 Direct F3, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.
F2 The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $49.6350 to $50.6275 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
F3 Restated to accurately report holdings that were misallocated in the Reporting Person's previous Form 4.
F4 The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.
F5 The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $50.64 to $51.3350 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
F6 Includes 75,358 restricted stock units.